Pacific Biosciences of California PACB Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's other working capital?
- Pacific Biosciences of California (PACB) reported other working capital of -$225K in Q1 2026.
- How has Pacific Biosciences of California's other working capital changed year-over-year?
- Pacific Biosciences of California's other working capital increased by 68.7% year-over-year, from -$719K to -$225K.
- What is the long-term trend for Pacific Biosciences of California's other working capital?
- Over 4 years (2021 to 2025), Pacific Biosciences of California's other working capital has grown at a 29.9% compound annual growth rate (CAGR), from $593K to -$1.69M.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.